It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
Wuhan City in the Hubei Province of the People’s Republic of China is on the Yangtze River and is the most populous city in central China. […]